Evaluating the construct of damage in systemic lupus erythematosus.
Johnson, SR; Gladman, DD; Brunner, HI; Isenberg, D; Clarke, AE; Barber, MR W; Arnaud, L; Fortin, PR; Mosca, M; Voskuyl, A; et al.
Arthritis Care and Research.
2021.
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis.
Balmuri, N; Soulsby, WD; Cooley, V; Gerber, L; Lawson, E; Goodman, S; Onel, K; Mehta, B; Abel, N; Abulaban, K; et al.
Pediatric Rheumatology.
2021;
19.
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Beukelman, T; Lougee, A; Matsouaka, RA; Collier, D; Rumsey, DG; Schenfeld, J; Stryker, S; Twilt, M; Kimura, Y; Abel, N; et al.
Pediatric Rheumatology.
2021;
19.
Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study.
Dave, I; Estroff, B; Gergely, T; Rostad, CA; Ponder, LA; McCracken, C; Prahalad, S; Abel, N; Abulaban, K; Adams, A; et al.
Journal of Rheumatology.
2021;
48:1856-1862.
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Ruperto, N; Brunner, HI; Synoverska, O; Ting, TV; Mendoza, CA; Spindler, A; Vyzhga, Y; Marzan, K; Grebenkina, L; Tirosh, I; et al.
The Lancet.
2021;
398:1984-1996.
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
van Vollenhoven, RF; Bertsias, G; Doria, A; Isenberg, D; Morand, E; Petri, MA; Pons-Estel, BA; Rahman, A; Ugarte-Gil, MF; Voskuyl, A; et al.
Lupus Science and Medicine.
2021;
8.
503 Developing a standardized steroid dosing regimen in pediatric proliferative lupus nephritis.
Brunner, HI; Rouster-Stevens, K; Klein-Gitelman, MS; Onel, K; Goilav, B; Ruth, N; Qiu, T; Aljaberi, N; Deng, J; Laskin, BL; et al.
Lupus Science and Medicine.
2021;
8:a13-a14.
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
Ruperto, N; Brunner, HI; Pacheco-Tena, C; Louw, I; Vega-Cornejo, G; Spindler, AJ; Kingsbury, DJ; Schmeling, H; Borzutzky, A; Cuttica, R; et al.
Rheumatology.
2021;
60:4495-4507.
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
Ruperto, N; Brunner, HI; Ramanan, AV; Horneff, G; Cuttica, R; Henrickson, M; Anton, J; Boteanu, AL; Penades, IC; Minden, K; et al.
Rheumatology.
2021;
60:4568-4580.
Clinicopathologic Conference: A Four-Year-Old Child With Digital Clubbing.
Schultz, K; Divanovic, A; Towe, C; Miethke, A; Wusik, K; Hammill, A; Brunner, H.
Arthritis Care and Research.
2021;
73:1379-1386.